PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23646149-0	2013	Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion.	Rosiglitazone	0-13	angiotensin I converting enzyme (peptidyl-dipeptidase A) 2	Mus musculus	85-116	
23646149-6	2013	Rosiglitazone treatment of db/db mice normalized hyperglycemia, attenuated renal injury and decreased urinary ACE2 and renal ADAM17 protein expression.	Rosiglitazone	0-13	angiotensin I converting enzyme (peptidyl-dipeptidase A) 2	Mus musculus	110-114	
23646149-10	2013	Therefore, it is tempting to speculate that renoprotection of rosiglitazone could be partially mediated via downregulation of renal ADAM17 and ACE2 shedding.	Rosiglitazone	62-75	angiotensin I converting enzyme (peptidyl-dipeptidase A) 2	Mus musculus	143-147